E-LIB Suche - Ergebnisse für: Zakko, Salam

1

Effects of Apremilast, an Oral Inhibitor of Phosphodiestera..:

Danese, Silvio ; Neurath, Markus F. ; Kopoń, Adam...
Clinical Gastroenterology and Hepatology. 18 (2020) 11 - p. 2526-2534.e9 , 2020

Link: https://doi.org/10.1016/..

2

Effects of Apremilast, an Oral Inhibitor of Phosphodiestera..:

Timothy C. Simmons ; Markus F. Neurath ; Ronald Fogel...
url:https://www.openaccessrepository.it/communities/itmirror. , 2019

Link: https://www.openaccessre..

3

813 - Apremilast for Active Ulcerative Colitis: A Phase 2, ..:

Danese, Silvio ; Neurath, Markus ; Kopon, Adam...
Gastroenterology. 154 (2018) 6 - p. S-167 , 2018

Link: https://doi.org/10.1016/..

4

Hydrogen and Methane-Based Breath Testing in Gastrointestin..:

Rezaie, Ali ; Buresi, Michelle ; Lembo, Anthony...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418558/. , 2017

Link: http://www.ncbi.nlm.nih...

5

450 Hydrogen- and Methane- Based Breath Testing (BT) in Gas..:

Rezaie, Ali ; Buresi, Michelle ; Lembo, Anthony...
Gastroenterology. 150 (2016) 4 - p. S97 , 2016

Link: https://doi.org/10.1016/..

6

Budesonide Foam Has a Favorable Safety Profile for Inducing..:

Rubin, David T. ; Sandborn, William J. ; Bosworth, Brian...
Digestive Diseases and Sciences. 60 (2015) 11 - p. 3408-3417 , 2015

Link: https://doi.org/10.1007/..

7

Long-Term Benefit of Mesalamine Granules for Patients Who A..:

Lichtenstein, Gary R. ; Gordon, Glenn L. ; Zakko, Salam...
Digestive Diseases and Sciences. 61 (2015) 1 - p. 221-229 , 2015

Link: https://doi.org/10.1007/..

8

Predicting a Response to Antibiotics in Patients with the I..:

Kasir, Rafid ; Zakko, Salam ; Zakko, Philip...
Digestive Diseases and Sciences. 61 (2015) 3 - p. 846-851 , 2015

Link: https://doi.org/10.1007/..

9

Budesonide Foam Induces Remission in Patients With Mild to ..:

Sandborn, William J. ; Bosworth, Brian ; Zakko, Salam...
Gastroenterology. 148 (2015) 4 - p. 740-750.e2 , 2015

Link: https://doi.org/10.1053/..

10

Long-Term Benefit of Mesalamine Granules for Patients Who A..:

Lichtenstein, Gary R ; Gordon, Glenn L ; Zakko, Salam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700064/. , 2015

Link: http://www.ncbi.nlm.nih...

11

Budesonide Foam Has a Favorable Safety Profile for Inducing..:

Rubin, David T ; Sandborn, William J ; Bosworth, Brian...
qt8jw8k5hv. , 2015

Link: https://escholarship.org..

12

1052 Daily Mesalamine Fails to Prevent Recurrent Diverticul..:

Kruis, Wolfgang ; Kardalinos, Vassilios ; Curtin, Austin...
Gastroenterology. 146 (2014) 5 - p. S-187 , 2014

Link: https://doi.org/10.1016/..

13

Mo1173 Safety Analysis of Budesonide Foam for Inducing Remi..:

Rubin, David T. ; Sandborn, William ; Bosworth, Brian P....
Gastroenterology. 146 (2014) 5 - p. S-577 , 2014

Link: https://doi.org/10.1016/..

14

Sa1174 Criteria of a Lactulose Breath Test Predictive of Re..:

Kasir, Rafid ; Zakko, Salam F. ; Lee, Aaron...
Gastroenterology. 146 (2014) 5 - p. S-219-S-220 , 2014

Link: https://doi.org/10.1016/..

15

Mo1224 Budesonide Foam for the Treatment of Patients With M..:

Bosworth, Brian ; Sandborn, William ; Zakko, Salam F....
Gastroenterology. 146 (2014) 5 - p. S-590 , 2014

Link: https://doi.org/10.1016/..